Misty is the love of my life she was not only my girlfriend but a friend of mine. I remember the first day I met her it was at school and JROTC she walked in with a big smile on her face. Even though my day was messed up she made it better, I pulled her out of formation to help her but I really just wanted to talk with her. She made me so happy I miss that smile of her’s. I loved that smile she had so much energy we started dating on 08/29/05. I remember all the good times we had and the plans we made but most of all I remember love we had between us. Nothing can stop that I will always love her and will never forget her or the times we had. I love her and miss her.
Love Jack
She was the one with all the beauty inside and out
This is my one true Angel
Subscribe to:
Post Comments (Atom)
2 comments:
SEROQUEL, ZYPREXA AND RISPERDAL INFORMATION
If you or someone you know has used Seroquel or Zyprexa and has suffered from diabetes, hyperglycemia, pancreatitis, or ketoacidosis, please contact our offices for a free case evaluation. At this time, we are not accepting new Risperdal cases.
Zyprexa Home | Zyprexa News | Seroquel News | Risperdal News | Submit a Case | Referring Attorneys
Pharmaceuticals & Medical Devices > Pharmaceuticals > Zyprexa Information
ZYPREXA and SEROQUEL ISSUES
Approved by the FDA to treat schizophrenia and bipolar disorder
Commonly prescribed to treat conditions such as dementia, attention deficit hyperactivity disorder (ADHD), gambling addictions, and postpartum depression
Use of Zyprexa has been linked with diabetes, hyperglycemia, pancreatitis, and ketoacidosis
Zyprexa is linked to at least 288 cases of diabetes and 23 deaths
Zyprexa increases the risk of death by cardiac events or infections in elderly dementia patients
50% of Zyprexa-related Ketoacidosis cases reportedly end in death
Public Citizen, a consumer advocacy group, has criticized the FDA for not adequately warning physicians and patients of Zyprexa's risks
The FDA reports that older patients treated with Zyprexa for dementia had a higher chance for death than patients who did not take the medicine.
Olanzapine is the generic name for Zyprexa.
Seroquel (quetiapine) and Risperdal (Risperidone) have also been linked to diabetes, hyperglycemia, pancreatitis , and ketoacidosis
Neuroleptic Malignant Syndrome & Tardive Dyskinesia are serious neurological disorders that can be caused by the use of Zyprexa, Seroquel and Risperdal.
If you think that you or someone you know has been injured by using Zyprexa, Seroquel or Risperdal, please contact our offices immediately.
Zyprexa is an antipsychotic medication approved by the FDA to treat schizophrenia and bipolar disorder. The world's best selling schizophrenia drug, Zyprexa sales account for 40% of Eli Lilly's $11 billion in annual sales. But this success has been darkened by a plethora of complaints due to life-threatening side effects that patients were previously unaware of. Zyprexa can cause diabetes and diabetes-related complications including coma and death. To date, in the United States, Zyprexa is linked to at least 288 cases of diabetes, including 23 deaths. Zyprexa has also been found to increase the risk of death by cardiac events or infections in elderly dementia patients.
USE OF THE DRUG
Manufactured by Eli Lilly and Company, olanzapine was approved by the FDA in 1996 under the brand name Zyprexa. Having been prescribed to over 6 million people worldwide, it is one of the biggest selling prescription drugs. Although Zyprexa has only been approved by the FDA to treat schizophrenia and bipolar disorder, it is commonly prescribed for other ailments, such as dementia, attention deficit hyperactivity disorder (ADHD), gambling addictions, and postpartum depression, to name a few.
DEVASTATING SIDE EFFECTS
Zyprexa has been the cause of at least 288 cases of diabetes and 23 deaths in the United States thus far. Additionally, hyperglycemia, pancreatitis and ketoacidosis have been reported amongst Zyprexa patients. Ketoacidosis, when associated to Zyprexa adverse effects, reportedly ends up fatal in about 50% of the cases. In a recent study, Zyprexa and two other atypical antipsychotics that are used to treat schizophrenia were found to cause diabetes 50 percent more often than older drugs.
Diabetes is a devastating, life long disease for which there is no cure. Diabetes is the number one cause of blindness, kidney failure and non traumatic limb amputation in the United States and the number two cause of cardiovascular problems. Diabetics are 2 to 4 times more likely to suffer from strokes and heart disease deaths than non-diabetics. Overall, diabetics are twice as likely to die as non-diabetics of the same age.
For this reason, it is important that you contact our offices immediately if you think that you or someone you know has been injured by using Zyprexa, Seroquel, or Risperdal.
FAILURE TO WARN
There have been many questions regarding Zyprexa and its safety. Knowledge of the potential dangers of Zyprexa were discovered as a result of a series of findings beginning in 2001 when the FDA was alerted to 19 case reports of diabetes associated with the drug. Zyprexa concerns were so great that Japan and the European Union required that clear strong diabetes warnings be included on Zyprexa labeling. The FDA has been criticized for failing to provide adequate information on Zyprexa to U.S. doctors and patients. Unlike other countries, the FDA has not required that Zyprexa labeling or informational packets provide black box warnings on the risk of diabetes faced by all Zyprexa patients.
Though risks of the drug might be considered to outweigh its benefits in severe cases, Zyprexa is being prescribed more and more for minor conditions that could be treated with a less risky drug. The Public Citizen consumer advocacy group has openly criticized the FDA for not adequately warning physicians and Zyprexa patients of the Zyprexa risks.
RESPONSE FROM THE FDA & ELI LILLY
In March of 2004, at the request of the FDA, the manufacturer Eli Lilly changed the Zyprexa label to include a warning about the link between Zyprexa and diabetes. Lilly also issued a "Dear Doctor" letter informing health care providers about the label changes. Instead of issuing a black box warning, which is prominently displayed on page 1 of the Prescribing Information, the warning was placed in the middle of the Warnings section on page 8 of the 32-page Prescribing Information insert.
Also, in March of 2004, the U.S. Attorney for the Eastern District of Pennsylvania announced a civil probe into Lilly's marketing and promotions of Zyprexa and the company's antidepressant Prozac. Lilly has agreed to cooperate with the U.S. Attorney's office as they conduct their investigations.
In April 2005, the FDA issued a Safety Alert to warn the public about the dangers of using Zyprexa in dementia patients. Following is an excerpt:
FDA has found that older patients treated with atypical antipsychotics for dementia had a higher chance for death than patients who did not take the medicine. This is not an approved use. FDA has asked the companies that make these medicines to change their labels to include this important information.
Eli Lilly subsequently changed their label to include a black box warning about the dangerous side effects of using Zyprexa in dementia patients.
In February 2005, a class action seeking damages of $900 million dollars was filed against Lilly in Canada. In the United States, there are currently approximately 8,000 claims filed against Lilly for diabetes-related Zyprexa side effects. U.S. lawsuits have been transferred into a multi-district litigation (MDL) in New York federal court. In June 2005, Lilly announced their offer to pay close to $1 billion dollars to settle most of the existing and new Zyprexa claims. In December 2005, it was reported that Lilly had sued 5 of their insurers to force them to pay half of those costs.
Although Zyprexa has not been removed from the market, sales have decreased in part due to the serious adverse risks and in part due to the availability of newer medications. Zyprexa sales from the second quarter of 2005 (April-June) dropped by 10% to a mere $1.1 billion dollars.
Interestingly, Lilly and Company currently manufactures several medications to treat diabetes, including Cymbalta approved in September 2004 and Byetta approved in April 2005. They anticipate seeking FDA approval on Arxxant, a drug used to treat diabetic complications in February of 2006. Lilly is also currently conducting Phase III clinical trials on a form of inhaled insulin.
SIMILAR MEDICATIONS
Zyprexa is not the only psychotropic medication under fire. Two other antipsychotic medicines, quetiapine and risperidone, have been found to cause the same devastating side effects as Zyprexa. Quetiapine is manufactured by AstraZeneca Pharmaceuticals, L.P. and is distributed under the brand name Seroquel (often mistakenly referred to as Seroquil). Risperidone is manufactured by Janssen Pharmaceutica Products, L.P. and is sold under the brand name Risperdal (often mistakenly referred to as Rispredol or Respirdal).
Please contact our offices immediately if you think that you or someone you know has been injured by using Zyprexa, Seroquel, or Risperdal.
LEGAL RECOURSE
Our law firm represents people who have been injured by Zyprexa or Seroquel. Time is running out quickly for making claims. The statute of limitations (deadline for filing a lawsuit) varies by state and depends on the specific facts of each case. If you do not file by the deadline, you lose your right to recover any money for your injury.
For this reason, it is important that you contact our offices immediately if you think that you or someone you know has been injured by using Zyprexa or Seroquel.
Click here for articles and information on Risperdal.
Click here for articles and information on Seroquel.
--------------------------------------------------------------------------------
Submit a Case
Referring Attorneys
Zyprexa Home | Nations' Law Links | Law Firm | Publications & Speeches | Disclaimer
Law Offices of Howard L. Nations, P.C.A National Pharmaceutical Litigation Firm
The Sterling Mansion | 4515 Yoakum Boulevard | Houston, TX 77006-5895
Telephone: 713-807-8400 / Toll Free: 1-800-269-3050 | FAX: 713-807-8423
E-mail: info@howardnations.com
Roy,
I just read your comments, thanks for your passion involving such mental health abuse. It is going to take people like you and me to stop this madness. Will be in touch need all the help and assistance I can get. Mary
Post a Comment